These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2769693)

  • 1. Neuropathy target esterase in hens after sarin and soman.
    Crowell JA; Parker RM; Bucci TJ; Dacre JC
    J Biochem Toxicol; 1989; 4(1):15-20. PubMed ID: 2769693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
    Jokanović M
    Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed neuropathy and inhibition of soluble neuropathy target esterase following the administration of organophosphorus compounds to hens.
    Tian Y; Xie XK; Piao FY; Yamauchi T
    Tohoku J Exp Med; 1998 Jul; 185(3):161-71. PubMed ID: 9823777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the delayed neurotoxicity of tributyl phosphate, tributoxyethyl phosphate, and dibutylphenyl phosphate.
    Carrington CD; Lapadula DM; Othman M; Farr C; Nair RS; Johannsen F; Abou-Donia MB
    Toxicol Ind Health; 1990; 6(3-4):415-23. PubMed ID: 2237927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the delayed neurotoxic potential of isopropyl triphenylphosphate using a nontraditional testing strategy.
    Sprague GL; Castles TR; Bickford AA
    J Toxicol Environ Health; 1984; 14(5-6):773-88. PubMed ID: 6520887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
    Moretto A; Bertolazzi M; Lotti M
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors.
    Ehrich M; Jortner BS; Padilla S
    Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed neuropathy and acute toxicity studies with pirimiphos-methyl in the hen.
    Lock EA; Johnson MK
    J Appl Toxicol; 1990 Feb; 10(1):17-21. PubMed ID: 2335708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic changes following treatment with organophosphorus-induced delayed neuropathy-producing agents in the adult hen.
    Robertson DG; Schwab BW; Sills RD; Richardson RJ; Anderson RJ
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):420-9. PubMed ID: 3564017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
    Fernando JC; Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute behavioural effects of the organophosphates sarin and soman in rats.
    Nieminen SA; Lecklin A; Heikkinen O; Ylitalo P
    Pharmacol Toxicol; 1990 Jul; 67(1):36-40. PubMed ID: 2395814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN).
    Veronesi B; Padilla S; Blackmon K; Pope C
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):311-24. PubMed ID: 1994513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of various areas of the nervous system of hens to TOCP-induced delayed neuropathy.
    Classen W; Gretener P; Rauch M; Weber E; Krinke GJ
    Neurotoxicology; 1996; 17(3-4):597-604. PubMed ID: 9086480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobehavioral toxicity with low doses of sarin and soman.
    Sirkka U; Nieminen SA; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):245-50. PubMed ID: 2374471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not.
    Johnson MK; Willems JL; De Bisschop HC; Read DJ; Benschop HP
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):34-41. PubMed ID: 3341026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
    Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
    Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of neuropathy target esterase inhibition to neuropathology and ataxia in hens given organophosphorus esters.
    Ehrich M; Jortner BS; Padilla S
    Chem Biol Interact; 1993 Jun; 87(1-3):431-7. PubMed ID: 8343999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low non-neuropathic tri-o-cresyl phosphate (TOCP) doses inhibit neuropathy target esterase near the neuropathic threshold in n-hexane pretreated hens.
    Pellin MC; Vilanova E; Barril J
    Toxicology; 1988 Apr; 49(1):99-105. PubMed ID: 3376128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of phosphofructokinase activity in relation to the pathogenesis of triorthocresyl-phosphate-induced delayed neuropathy.
    Hernández AF; Pla A; Villanueva E
    Rev Esp Fisiol; 1992 Sep; 48(3):139-46. PubMed ID: 1301629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in spinal cord reflexes following subchronic exposure to soman and sarin.
    Goldstein BD
    Toxicol Lett; 1989 Apr; 47(1):1-8. PubMed ID: 2711412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.